Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol oil for pain and burning relief in burning mouth syndrome
RBR-8mqxc4bPhase 2Recruiting
- Sponsor
- Hospital de Clínicas da Universidade Federal do Paraná
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of cannabidiol in glossodynia (BMS) (2 arms), sponsored by Hospital de Clínicas da Universidade Federal do Paraná. Started Mar 2025; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
glossodynia (BMS)
Beyond the preview
Go deeper on RBR-8mqxc4b.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8mqxc4b.